SCD most commonly stands for sickle cell disease, a genetic blood disorder that affects roughly 7.74 million people worldwide. It causes red blood cells to become rigid and crescent-shaped, blocking blood flow and triggering episodes of severe pain. The abbreviation can also refer to sudden cardiac death or the specific carbohydrate diet, both covered briefly at the end of this article.
How Sickle Cell Disease Works
Healthy red blood cells are round and flexible, sliding easily through blood vessels to deliver oxygen. In sickle cell disease, a mutation in the gene responsible for making hemoglobin (the oxygen-carrying protein inside red blood cells) produces an abnormal version called hemoglobin S. When hemoglobin S releases its oxygen, the molecules clump together inside the cell, forcing it into a stiff, sickle-shaped form. These misshapen cells don’t flow smoothly. They stick to blood vessel walls and to white blood cells, creating blockages that starve nearby tissue of oxygen.
Sickle cell disease is inherited in an autosomal recessive pattern, meaning a child must receive one copy of the mutated gene from each parent. If only one copy is inherited, the person carries the sickle cell trait but typically does not develop symptoms. Two carrier parents have a 25 percent chance with each pregnancy of having a child with the disease.
Who Is Affected
The disease is most common among people whose ancestors came from regions where malaria is or was widespread: sub-Saharan Africa, the Caribbean, Central and South America, Saudi Arabia, India, and Mediterranean countries like Turkey, Greece, and Italy. Sub-Saharan Africa accounts for nearly 80 percent of global cases, with roughly 515,000 affected babies born each year. In the United States, an estimated 100,000 people live with the disease. It occurs in about 1 out of every 365 Black or African American births and about 1 in 16,300 Hispanic American births.
The mortality burden is significant. In 2021, sickle cell disease caused an estimated 81,100 deaths in children under five, making it the 12th leading cause of death in that age group globally. Traditional death records dramatically undercount its impact. According to the World Health Organization, actual deaths are roughly 11 times higher than cause-specific statistics suggest.
Pain Crises: The Hallmark Symptom
The most recognizable feature of sickle cell disease is the vaso-occlusive crisis, commonly called a pain crisis. When sickled cells block small blood vessels, the tissue downstream loses oxygen and begins to die, producing intense pain that can strike the chest, abdomen, joints, or bones. A typical crisis follows a pattern: it begins with a low-intensity ache lasting about three days, then escalates rapidly to peak pain as tissue damage sets in. The severe, constant pain phase usually lasts three to five days, driven by the body’s inflammatory response. Resolution takes another one to two days.
Pain crises can be triggered by dehydration, cold temperatures, physical exertion, stress, or infection, though sometimes they arise without an obvious cause. Their frequency varies widely from person to person.
Acute Chest Syndrome and Other Complications
Acute chest syndrome is one of the most dangerous complications. It involves a new area of blockage visible on a chest X-ray, combined with respiratory symptoms like coughing, wheezing, chest pain, or difficulty breathing, often with fever above 38.5°C (about 101°F). It can progress rapidly and requires urgent hospital treatment with fluids, antibiotics, supplemental oxygen, and sometimes blood transfusions.
Other complications include stroke, organ damage (particularly to the spleen, kidneys, and liver), chronic anemia, increased susceptibility to infections, and vision problems caused by blocked blood vessels in the eyes. Over time, repeated episodes of oxygen deprivation take a cumulative toll on the body’s organs.
Diagnosis and Newborn Screening
In the United States, all 50 states screen newborns for sickle cell disease through a simple heel-prick blood test performed shortly after birth. The blood sample is analyzed using specialized lab techniques that separate and identify different types of hemoglobin. If the initial screen suggests sickle cell disease or trait, a follow-up team contacts the family to confirm with repeat testing. Early diagnosis is critical because it allows preventive care, including antibiotics and vaccinations, to begin before life-threatening infections can take hold.
Long-Term Management With Medication
The most established medication for sickle cell disease works by boosting the body’s production of fetal hemoglobin, a form of hemoglobin that naturally resists sickling. In a landmark clinical trial, patients taking this medication had a median of 2.5 pain crises per year compared to 4.5 in those taking a placebo. The time to a first crisis doubled (3 months versus 1.5 months), and far fewer patients developed acute chest syndrome or needed blood transfusions. Fetal hemoglobin levels rose as high as 15 to 20 percent in some patients, substantially reducing the proportion of cells that sickle.
Blood transfusions are another key tool, particularly for preventing stroke in children identified as high risk through regular screening.
Gene Therapy: A Potential Cure
In December 2023, the FDA approved two gene therapies for sickle cell disease in patients 12 and older, marking a major turning point. One of them is the first FDA-approved treatment to use CRISPR gene-editing technology. It works by collecting a patient’s own blood stem cells, editing their DNA to boost fetal hemoglobin production, and transplanting the modified cells back into the bone marrow. Higher fetal hemoglobin levels prevent red blood cells from sickling.
The second approved therapy uses a different approach: a viral delivery vehicle inserts a gene that produces a modified hemoglobin functioning like normal adult hemoglobin. Red blood cells carrying this engineered hemoglobin are far less likely to sickle and block blood flow. Both therapies require intensive preparation, including chemotherapy to clear existing bone marrow before the modified cells are infused, and a lengthy recovery period. They are currently reserved for patients with frequent pain crises.
Other Meanings of SCD
Sudden Cardiac Death
SCD also stands for sudden cardiac death, defined as death from a cardiovascular cause within one hour of symptom onset, or within 24 hours of being last seen healthy. It is most often caused by a sudden, fatal heart rhythm disturbance. Coronary artery disease accounts for more than 75 percent of cases in developed countries. Key risk factors include a history of heart attack, heart failure, smoking (which raises risk 2.5-fold according to the Framingham study), and a family history of sudden cardiac events. In younger people, inherited heart rhythm disorders are a more common cause.
Specific Carbohydrate Diet
The specific carbohydrate diet is an eating plan that eliminates hard-to-digest carbohydrates, particularly grains, grain products, and most sugars. It is primarily used by people with inflammatory bowel disease and other digestive disorders. The idea is that removing complex carbohydrates starves harmful gut bacteria of their fuel, potentially reducing inflammation and symptoms. Foods off-limits include bread, pasta, cereal, rice, corn, oats, candy, high-fructose corn syrup, most dairy products, and processed sugars. The diet permits carbohydrates that are easier to absorb, such as fruits, vegetables, and certain aged cheeses.